How many insider trades does FilingIQ track for NTHI?

FilingIQ tracks 86 Form 4 insider transactions for NTHI (NEONC TECHNOLOGIES HOLDINGS, INC.), covering filings from Mar 26, 2025 onwards. 12 of those were filed in the last 90 days.

Are NTHI insiders net buyers or net sellers?

Across the full Form 4 history for NTHI, 32 transactions (37%) were open-market purchases and 20 (23%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NTHI insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is NTHI in?

NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $173.51M.

NTHI insider trading

NasdaqGM Healthcare

NEONC TECHNOLOGIES HOLDINGS, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

37% / 23%

Market cap

$173.51M

About NEONC TECHNOLOGIES HOLDINGS, INC.

NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.

Company website: www.neonc.com

NTHI insider activity at a glance

FilingIQ has scored 86 insider transactions for NTHI since Mar 26, 2025. The most recent filing in our index is dated May 1, 2026.

Across the full history, 32 open-market purchases and 20 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NTHI insider trades is 53.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NTHI trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for NTHI?: FilingIQ tracks 86 Form 4 insider transactions for NTHI (NEONC TECHNOLOGIES HOLDINGS, INC.), covering filings from Mar 26, 2025 onwards. 12 of those were filed in the last 90 days.
Are NTHI insiders net buyers or net sellers?: Across the full Form 4 history for NTHI, 32 transactions (37%) were open-market purchases and 20 (23%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NTHI insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is NTHI in?: NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $173.51M.

Methodology & sources

Every NTHI insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.